|
Session 123-Poster Abstracts
Hepatitis B: Epidemiology and Prevention
Wednesday, 2-4 pm; Poster Hall |
623
 |
A Randomized Controlled Trial Comparing the Efficacy and Safety of 4 Intramuscular Double Doses or 4 Intradermal Low Doses with 3 Intramuscular Standard Doses of HBV in HIV-infected Adults: Results of the ANRS HB03 VIHVAC-B Trial
Odile Launay*1, D van der Vliet1, A Rosenberg1, M-L Michel2, O Lortholary3, N Colin de Verdière4, L Slama5, L Piroth6, D Rey7, F Carrat8, and ANRS HB03 Trial Group
1Univ Paris Descartes, Hosp Cochin, France; 2Inst Pasteur, Paris, France; 3Univ Paris Descartes, Hosp Necker, France; 4Hosp Saint Louis, Paris, France; 5Hosp Tenon, Paris, France; 6Hosp Haut Bocage, Dijon, France; 7Hosp Univ, Strasbourg, France; and 8Univ Pierre and Marie Curie, Hosp Saint Antoine, Paris, France |
624
|
Accelerated Hepatitis B Vaccination Schedule in HIV-infected Patients
Theodora de Vries-Sluijs*, B Hansen, G van Doornum, H Janssen, M van der Ende, and R de Man
Erasmus Med Ctr, Rotterdam, The Netherlands |
625
|
Hepatitis B Vaccine Response Predicts Progression to Clinical AIDS or Death
Michael Landrum*1,2, K Huppler Hullsiek1,3, N Crum-Cianflone1,4, A Weintrob1,5, A Ganesan1,6, J Okulicz2, R O’Connell7, S Ahuja8, B Agan1, and IDCRP HIV Working Group
1Uniformed Svcs Univ of the Hlth Sci, Bethesda, MD, US; 2San Antonio Military Med Ctr, Fort Sam Houston, TX, US; 3Univ of Minnesota, Minneapolis, US; 4Naval Med Ctr San Diego, CA, US; 5Walter Reed Army Med Ctr, Washington, DC, US; 6Natl Naval Med Ctr, Bethesda, MD, US; 7Walter Reed Army Inst of Res, Rockville, MD, US; and 8Univ of Texas Hlth Sci Ctr at San Antonio, US |
626
|
Genotype G HBV and Advanced Liver Fibrosis in HIV/HBV Co-infected Patients
Doan Dao*, J Balko, N Attar, E Neak, H-J Yuan, W Lee, and M Jain
Univ of Texas Southwestern Med Ctr, Dallas, US |
627
|
HBV DNA Is Not Detected in the Semen of Patients with Chronic Hepatitis B and Undetectable Serum HBV DNA as a Result of Nucleotide Antiviral Treatment
Ann Marie Liapakis*1, M Patel2, E Kula3, D Zhang3, F Ye3, J Wu3, M Woodward3, D Dieterich3, and M-L Vachon3
1New York Presbyterian Weill Cornell Med Ctr, NY, US; 2Warren Alpert Med Sch of Brown Univ, Rhode Island Hosp, Providence, US; and 3Mt Sinai Med Ctr, New York, NY, US |
628
|
Clinical and Laboratory Factors Associated with Isolated Hepatitis B Core Antibody Status among HIV-infected Subjects in the Multicenter AIDS Cohort Study
Gunter Rieg*1, R Lewis1, E Seaberg2, S Badri3, C Rinaldo4, C Thio5, and M Witt1
1Los Angeles Biomed Res Inst at Harbor-UCLA, Torrance, US; 2Johns Hopkins Univ Bloomberg Sch of Publ Hlth, Baltimore, MD, US; 3Cook County Bureau of Hlth Svcs, Chicago, IL, US; 4Univ of Pittsburgh, PA, US; and 5Johns Hopkins Univ Sch of Med, Baltimore, MD, US |
629
|
Hepatitis B Viruses Infecting Wild African Great Apes
Weimin Liu*1, Y Li1, G Learn1, J-B Ndjango2, P Goepfert1, F Leendertz3, M K Gonder4, M Peeters5, B Hahn1, and P Sharp6
1Univ of Alabama at Birmingham, US; 2Univ of Kisangani, Democratic Republic of the Congo; 3Robert Koch Inst, Berlin, Germany; 4State Univ of New York, Albany, US; 5Univ of Montpellier, France; and 6Univ of Edinburgh, UK |
|
